Evidence map›Paper›PMID 40267227›Full record

ArticleBlood advances2025

Genetic deregulation of REL in germinal center B cells induces generation of a pool of lymphoma precursor cells.

Léa Prévaud, Karima Ferhat, Dilara Sensoy, Ophélie Téteau, Tiffany Marchiol, Quentin Lemasson, Catherine Ouk, Claire Carrion, Michel Cogné, Jean Feuillard and 2 more

Abstract read
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. HemaSphere · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Léa PrévaudUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.
Karima FerhatUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.ORCID 0009-0008-2650-5791
Dilara SensoyUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.ORCID 0009-0007-3867-1933
Ophélie TéteauUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.
Tiffany MarchiolUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.ORCID 0000-0003-0714-1191
Quentin LemassonUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.
Catherine OukUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.
Claire CarrionUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.ORCID 0000-0003-3221-6319
Michel CognéUnité Mixte de Recherche Institut National de la Santé Et de la Recherche Médicale U1236, Université de Rennes and Etablissement Français Du Sang Bretagne, Rennes, France.ORCID 0000-0002-8519-4427
Jean FeuillardUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.ORCID 0000-0001-6223-2454
Christelle Vincent-FabertUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.ORCID 0000-0002-5799-980X
Nathalie FaumontUnité Mixte de Recherche Centre National de la Recherche Scientifique 7276/Institut National de la Santé Et de la Recherche Médicale U1262 Contrôle de la Réponse Immune B et Lymphoproliférations, Université de Limoges, Limoges, France.ORCID 0000-0002-6118-3168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractIn diffuse large B-cell lymphomas (DLBCLs), gains and amplifications of the 2p15-16 region, which always encompass the REL gene, are mostly restricted to the germinal center (GC) B-cell DLBCL subtype (GCB-DLBCL) for which c-Rel is the pivotal Rel/NF-κΒ subunit. Although REL plays a key role in the GC reaction, its contribution to GCB-DLBCLs remains unclear.To understand the role of REL in the very first steps of GCB transformation, that is, when B cells with deregulated REL are competing with other B cells during chronic antigenic stimulation, we have created a dual-color mouse model that allows to induce REL in a limited pool of activation-induced cytidine deaminase (AID)-imprinted B cells after immunization and to differentially stain AID-imprinted B cells that overexpress REL or not. Dysregulation of REL in AID-imprinted B cells was associated with nuclear c-Rel overexpression in GCs 14 days after immunization. Dysregulation of REL at the GCB stage promoted GCB expansion, which was associated with both class-switch recombination and plasma cell differentiation. REL overexpression conferred a long-term competitive advantage, allowing GC persistence and continuous recirculation of REL-overexpressing B cells. IgHV dominance was increased at the messenger RNA level in REL-overexpressing B cells and clonal expansion was detected at the DNA level in some cases. Highlighting the role of the immune response, our results demonstrate the advantage conferred by REL in the GC competition and provide evidence that, as an oncogenic event of GCBs, its genetic deregulation induces the generation of a long-term pool of lymphoma precursor cells.

Indexed as

B-LymphocytesGene Expression Regulation, NeoplasticGerminal CenterLymphoma, Large B-Cell, DiffuseProto-Oncogene Proteins c-relAICDA (Activation-Induced Cytidine Deaminase)AnimalsCell DifferentiationCytidine DeaminaseHumansMiceAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseProto-Oncogene Proteins c-rel

Identifiers

PMID40267227
PMCPMC12305208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.